SCHEMBL762815

SCHEMBL762815

Cn1nc2sc(C(=O)OC(C)(C)C)cc2c1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
CSNK2A2 P19784 3/20 0.36
CSNK2B P67870 3/20 0.36
CSNK2A1 P68400 3/20 0.36
KDR P35968 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 5/20 0.35
DAPK3 O43293 1/20 0.34
CSNK1A1 P48729 1/20 0.34
LIMK1 P53667 1/20 0.34
TNK2 Q07912 1/20 0.34
ROCK1 Q13464 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
GRM6 O15303 1/20 0.33
HSP90AB1 P08238 1/20 0.33
DHFR P00374 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762871 0.78 NPC1 (0.52) NPC1PKMPIM3PIM2L3MBTL1
SCHEMBL26983433 0.70 CSNK2A2 (0.55) NPC1PKMPIM3PIM2CSNK2A2
SCHEMBL742358 0.69 KDM4E (0.43) NPC1PKMPIM3PIM2L3MBTL1
SCHEMBL742663 0.69 CSNK2A2 (0.40) CSNK2A2CSNK2BCSNK2A1KDRALDH1A1
SCHEMBL17796531 0.67 KDM4E (0.40) NPC1PKMALDH1A1GRM6HSP90AB1
SCHEMBL14200571 0.65 KDM4E (0.43) NPC1L3MBTL1ALDH1A1KDM4EGLA
SCHEMBL17900427 0.64 GRM6 (0.43) L3MBTL1ALDH1A1GRM6KDM4EHPGD
SCHEMBL8549434 0.64 TSHR (0.44) L3MBTL1ALDH1A1GRM6HPGDHSD17B10
SCHEMBL8498605 0.64 GRM6 (0.40) ALDH1A1GRM6GAACISD2
SCHEMBL27805811 0.64 GRM6 (0.40) NPC1PKML3MBTL1ALDH1A1GRM6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed